No Detail Found!

Comparison of Postoperative Analgesia with 0.8 Mg and 1.6 Mg Intrathecal Nalbuphine; a Randomized Controlled Trial.

Author(s)
Prasanna Vadhanan Department of Anesthesiology, Vinayaka Missions Medical College and Hospitals (VMMC), Karaikal 609 609, Pondicherry, India
Kiruthika Balakrishnan Department of Anesthesiology, Vinayaka Missions Medical College and Hospitals (VMMC), Karaikal 609 609, Pondicherry, India
Abstract
Background & Objectives: Intrathecal opioids provide an easy and efficient method of prolonging postoperative analgesia due to its action on the spinal opioid receptors. Nalbuphine is a mixed opioid agonist - antagonist which has better side effect profile than morphine. It is easily available in India without a need for narcotics license. The optimal dose of nalbuphine as an adjuvant to intrathecal bupivacaine is not known, as the availability of other narcotics, e.g. fentanyl, sufentanyl etc., in the West has diminished the need to use, and thus to research partial opioids like nalbuphine. The aim of our study was to compare the duration of postoperative analgesia with 0.8 mg and 1.6 mg of nalbuphine when used as an additive with 0.5% hyperbaric bupivacaine in patients undergoing lower abdominal and lower limb surgeries. Methodology: 66 patients undergoing various lower abdominal and lower limb surgeries were randomized into 2 groups and received either 0.8 mg or 1.6 mg intrathecal nalbuphine with 3.2 ml of 0.5% hyperbaric bupivacaine. The duration of postoperative analgesia, hemodynamic stability and incidence of adverse effects were noted. Results: The mean duration of postoperative analgesia in 0.8 mg and 1.6 mg group were 247 ± 12 and 239 ± 10 min respectively (p = 0.007). The incidence of bradycardia was more in 1.6 mg group but did not reach statistical significance. The inability of the higher dose to achieve longer analgesia might be due to a ceiling effect and anti-analgesic actions of nalbuphine. Conclusion: A dose of 0.8mg of nalbuphine as an intrathecal adjuvant seems to be optimal for providing prolonged post operative analgesia with minimal side effects.
Publication Details
Page(s) 37-43
DOI DOI not available
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 21, Issue: 1, Year: 2017

Request the full text from PASTIC

References
Res, 2010., 1 97 -108
.,2008 Jul 15 233 -
2008., 04 -
2015.,Controlled Trials Sci Rep 5 -
., 10 -
2014., 28 18 -23
.fentanyl as adjuvant to 0.5% hyperbaric, -
2016.A comparative evaluation,Indian J Pain 30 90 -95
2015.,[cited 20th May -
MukherjeeA,PalA,AgrawalJ,MehrotraA,DawarN., 2011.Intrathecal nalbuphine as an adjuvant to subarachnoid block: What is the most effective dose? Anesth Essays Res, 10 94759 -1162
GomaaHH,MohamedNN,ZoheirHAH,AliMS, 2014.A comparison between postoperative analgesia after intrathecal nalbuphine with bupivacaine and intrathecal fentanyl with bupivacaine after cesarean section,Egypian J Anaesth 30 405 -410
TiwariAK,TomarGS,AgrawalJ, 2013.Intrathecal bupivacaine in comparision with a combination of nalbuphine and bupivacaine for subarachnoid block: A randomized prospective double blind clinical study,Am J Ther 10 592 -5
GearR,BecerraL,UpadhyayJ,BishopJ,WallinD,PendseG, 2013.Pain facilitation brain regions activated by nalbuphine are revealed by pharmacological fMRI,PLoS One 0050169 -
GearRW,GordonNC,HossainiZadehM,LeeJS,MiaskowskiC,PaulSM, 2007.A subanalgesic dose of morphine eliminates Nalbuphine antianalgesia in postoperative pain,J Pain 11 337 -41
RasakhamK,Liu-ChenLY, 2010.Sex differences in kappa opioid pharmacology,Life Sci. 2011 Jan 10 10 -
EbertTJ,NovalijaJ,UhrichTD,BarneyJA, 2015.The effectiveness of oxygen delivery and reliability of carbon dioxide waveforms: a crossover comparison of 4 nasal cannulae,Anesth Analg 10 342 -8
ZhangC,WangM,WangR,WangW., 2013.Accuracy of end-tidal CO2 measurement through the nose and pharynx in nonintubated patients during digital subtraction cerebral angiography,J Neurosurg Anesthesiol 10 191 -6
0

Citations

0

Downloads

61

Views